Vanguard Group Inc Neuro Pace Inc Call Options Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NPCE
# of Institutions
108Shares Held
21.4MCall Options Held
3.14MPut Options Held
68.6K-
Orbimed Advisors LLC San Diego, CA2.61MShares$25.7 Million1.04% of portfolio
-
Morgan Stanley New York, NY2.59MShares$25.4 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.31MShares$22.7 Million2.0% of portfolio
-
First Light Asset Management, LLC Edina, MN1.38MShares$13.6 Million2.36% of portfolio
-
Armistice Capital, LLC New York, NY1.15MShares$11.3 Million0.22% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $244M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...